Similar Articles |
|
Pharmaceutical Executive August 1, 2008 George Koroneos |
Hard of (Ad)hering Companies have responded to declining profits with a proliferation of patient compliance programs. But where is pharma in this paradigm shift? |
Pharmaceutical Executive June 1, 2006 Philip A. George |
Alternative Media: Online Med Sites Gain Patient Trust Pharma could benefit from a little less TV. |
Pharmaceutical Executive November 1, 2008 |
No Ordinary Joe It's been a year since consumer marketing master Joe Jimenez took over the top spot at Novartis Pharma. How's he faring? |
Pharmaceutical Executive May 1, 2007 Diane West |
Spend Trends 2007: Hang 10 Direct-to-Consumer Advertising Hits Its First Decade: Dr. Dot-Com... Digital Detailing... etc. |
Pharmaceutical Executive August 1, 2011 Jennifer Ringler |
The Adherence Fight: A TKO? Why does the match against medicines compliance always seem to end in an easy knockout? |
Pharmaceutical Executive February 1, 2007 Bill Chekan |
Ain't Misbehavin' Missing doses and other medication meddling are often no accident. A new study of patient compliance uncovers methods to the madness. |
Pharmaceutical Executive July 3, 2007 |
Direct to Consumer: The Secret of My Success Pharmaceutical industry experts sound off on the methods behind an award-winning ad and how the next great direct-to-consumer campaign will come about. |
Pharmaceutical Executive November 1, 2005 Peter H. Nalen |
Alternative Media: Targeting Audiences on the Web The most important web page to communicate with doctors and patients is the page of results that your potential customers see when they use search engines, such as Google, Yahoo!, or MSN. |
Pharmaceutical Executive August 1, 2011 Peter Houston |
Google+ and Pharma Is Google+ the social media platform that pharma has been waiting for? |
Pharmaceutical Executive February 1, 2014 Longacre et al. |
Social Media: Have We Reached The Tipping Point? For pharma marketers, the good news is recent advances in social media monitoring make it possible to listen to or engage with patients on social media websites. This month FDA released its draft guidance on the use of "Interactive Promotional Media." |
Pharmaceutical Executive March 1, 2007 Maraldo & Lister |
Back Page: Let's Get Gutsy Pharma gets no respect from the public. But instead of complaining about it, industry should stop whining and start leading. Here's a seven-point starter kit. |
Pharmaceutical Executive September 1, 2005 Wolfgang Klietmann |
Thought Leader: (Eco)systemic Change The author discusses how various players within the healthcare system interact. |
Pharmaceutical Executive July 30, 2007 Stewart Young |
Marketing to Professionals: The Essence of a Brand Beyond good messaging, marketers must establish a brand that is forever etched into physicians' minds. |
Pharmaceutical Executive August 1, 2006 Patrick Clinton |
From the Editor: Take Your Seat There's a lot to accomplish in the pharmaceutical industry. But considering what the industry has done in 25 years, it's not impossible. |
Pharmaceutical Executive February 1, 2009 Patrick Clinton |
Working Together No one who cares about global health can be happy with a system that only "eventually" delivers drugs and vaccines for the planet's neediest people. |
Pharmaceutical Executive June 1, 2009 Michael Maher |
Learning to Relate A multi-phase implementation strategy can debunk the myth that social media won't work for pharma. |
Pharmaceutical Executive April 1, 2012 |
Ad Stars The campaigns chosen as this year's Pharm Exec Ad Stars include a diverse mix of clients, health conditions, and media channels. |
Chemistry World December 4, 2012 Andrew Turley |
Drug R&D costs rising Inventing a new drug costs an enormous amount of money. It's part of the reason why the pharma industry is struggling to fill its pipelines. But we'd like to think that -- however slowly -- that cost is coming down. Unfortunately it isn't. |
Pharmaceutical Executive June 1, 2012 Amy Smith |
Marketing: Medical Devices vs. Pharma Understanding the differences between drug and device marketing can make or break the brand's promotional activities. |
Pharmaceutical Executive December 1, 2011 William Looney |
The Medicines Adherence Challenge Keeping skittish patients on their medicines ought to be a strategic priority for Big Pharma, but is it? An expert round table examines how best to make progress and agree on some practical steps for incorporation in the campaign agenda. |
The Motley Fool April 27, 2006 Stephen D. Simpson |
A Sluggish Bristol-Myers Squibb Generic erosion is going to chew away revenue and profits. Investors, at today's prices, there are just too many other better ideas to go after. |
Pharmaceutical Executive January 1, 2006 Maggie Helmig |
Direct to Consumer: Patient Education Reform Marketers can empower patients to start a dialogue with their doctors. |
Pharmaceutical Executive February 1, 2006 Chandler & Chicco |
Public Relations: Damage Control Unless pharma defines a compelling story, and defends it vigorously in the consumer marketplace, others will enter that vacuum and tell the story for it -- in far less flattering ways |
Pharmaceutical Executive December 1, 2005 Meg Columbia-Walsh |
Direct to Consumer: Culturally Relevant Marketing Through culturally relevant marketing, pharma can seamlessly weave its brands into consumers' lives... Also: The 2005 Pharmaceutical Advertising and Marketing Excellence Award recipients... |
Pharmaceutical Executive May 1, 2009 Maryann Kuzel |
Weathering the Storm Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market. |
The Motley Fool December 13, 2004 Brian Gorman |
Which Medications Are Your Best Bets? Consumer Reports' effort to rate drugs offers a marketing lesson to pharmaceutical companies. |
Pharmaceutical Executive May 1, 2007 |
Thoughtleader: Thomas Nagle, Strategic Pricing Group This industry consultant believes the U.S. government will soon follow Europe's lead in taking a greater hand in price negotiations, and pharma will need to be able to communicate the value that products offer. Here he discusses how pharma can meet that challenge. |
Pharmaceutical Executive September 1, 2011 |
Pharma and Social Media: Ready to Make Nice? The time is right for industry to overcome its social media phobia once and for all. |
Pharmaceutical Executive January 1, 2006 Gina Ashe |
Alternative Media: Patient Bloggers on Your Brands Find out what patient bloggers are saying about your pharmaceutical brands. |
Pharmaceutical Executive February 1, 2009 David Johnson |
Dive into Digital Exclusive Pharma Exec survey details how pharma can make virtual channels effective marketing vehicles. |
Pharmaceutical Executive November 1, 2008 George Koroneos |
Tech Toys Here are the hottest gadgets and gizmos to make a dent in drug noncompliance. |
Pharmaceutical Executive May 1, 2005 Kathy Kastner |
Direct to Consumer: Information vs. Education Although the pharma industry is good at providing information, it has not yet learned how to transform it into reliable education. If pharma marketers can initiate that transformation, they will grab a significant opportunity to connect with consumers. |
Pharmaceutical Executive October 1, 2005 |
Public Relations: Communications Delivery Chain An interview with Nanccy Turett, president of Edelman Health on how, to regain consumers' trust, pharma must better communicate its mission, goals, and policies. |
Pharmaceutical Executive May 1, 2006 Stephen Wray |
Alternative Media: Interactive=Integration Interactive technology allows marketers to keep up with the demands of both physicians and consumers. |
Pharmaceutical Executive April 1, 2007 Fard Johnmar |
Alternative Media: Mastering Social Media Pharma agencies are buzzing about social media tools such as blogs, podcasts, and interactive healthcare forums, but few firms really know how to make these online initiatives work. |
Pharmaceutical Executive June 1, 2011 |
Emerging Pharma Leaders 2011 Meet 2011's Emerging Pharma Leaders. Can these 30 trendsetters build competitive scale from scarcity? |
Pharmaceutical Executive May 1, 2009 Lee Slovitt |
A Day Late and a Dollar Short Pharma marketers face a crisis in digital media. But there's a way to turn it around. |
Pharmaceutical Executive July 1, 2009 Patrick Clinton |
What to Buy In the long run, pharma wants to sell health, not just drugs. |
Pharmaceutical Executive May 1, 2009 |
Ad(Ventures) in Pharmaland Despite the downside in ad spend, an upside remains in the digital space that's wide open for exploration. |
Pharmaceutical Executive October 1, 2008 Patrick Clinton |
Future Shock A vision of pharma's next business model is starting to emerge. But how do we get from here to there? |
Pharmaceutical Executive March 1, 2011 |
Pharm Exec's Seventh Annual Media Audit Negative views regarding pharma are on the rise, but vaccines help keep the focus on the positives of innovation. |
Pharmaceutical Executive January 1, 2007 Walter Armstrong |
Forecast 2007: At Sea In times of crisis, it's harder than ever to take the long view. The healing arts may be as old as humankind, but the business of pharma is still in its infancy. |
Pharmaceutical Executive February 1, 2007 Daniella Koren |
Direct to Consumer: One Size Fits You Custom-tailored e-mail campaigns yield high marks from consumers. |
Pharmaceutical Executive February 1, 2009 Joanna Breitstein |
Vaccines for All The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most. |
Pharmaceutical Executive January 1, 2007 Glass & Poli |
Forecast 2007: Connecting the Dots How do execs rank the issues facing the pharmaceutical industry? And what are the links they see between them? A new study reveals the industry's mental map of today's challenges. |
Pharmaceutical Executive October 1, 2011 |
Arming up for the Digital Revolution As a longtime advocate of new approaches to meeting customer needs in pharma, Martin Wygod sees the biggest change as the coming growth of digital platforms as the principal source of information and communication in healthcare. |
Pharmaceutical Executive September 1, 2005 Wilkenfeld & Braun-Davis |
50 5 2005 Five things pharmaceutical companies can do to prepare for compliance in all 50 states. |
Pharmaceutical Executive August 1, 2013 Peter Houston |
The Case for Content Reaching skittish consumers through objective, story driven information is digital marketing's hottest digit. But applying this consumer phenomenon in Big Pharma presents some unique challenges. |
Pharmaceutical Executive June 1, 2005 Zimmerman & Fay |
Marketing to Professionals: Dr. Ambassador The pharma industry is under siege in the news media. Smart companies must create a role for physicians as ambassadors who can raise patient confidence in drugs and the pharma industry as a whole. |
HBS Working Knowledge February 28, 2005 Cynthia Churchwell |
Funding R&D for Neglected Diseases Research on vaccines for diseases that primarily affect low-income countries remains minimal---the risks are too high for developers. The book Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases suggests a solution. |